Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript

2026-02-06 13:24:18 ET

Immunovant, Inc. (IMVT) Q3 2026 Earnings Call February 6, 2026 8:00 AM EST

Company Participants

Benjamin Zimmer - President of Health

Conference Call Participants

Stephanie Lee Griffin - Roivant Sciences Ltd.
Matthew Gline - Roivant Sciences Ltd.
Corinne Jenkins - Goldman Sachs Group, Inc., Research Division
David Risinger - Leerink Partners LLC, Research Division
Yaron Werber - TD Cowen, Research Division
Lut Ming Cheng - JPMorgan Chase & Co, Research Division
Anthea Li - Jefferies LLC, Research Division
Yasmeen Rahimi - Piper Sandler & Co., Research Division
Prakhar Agrawal - Cantor Fitzgerald & Co., Research Division
Samantha Semenkow - Citigroup Inc., Research Division
Yatin Suneja - Guggenheim Securities, LLC, Research Division
Douglas Tsao - H.C. Wainwright & Co, LLC, Research Division
Derek Archila - Wells Fargo Securities, LLC, Research Division
Ashwani Verma - UBS Investment Bank, Research Division
Thomas Smith - Leerink Partners LLC, Research Division
Alexander Thompson - Stifel, Nicolaus & Company, Incorporated, Research Division
...

Read the full article on Seeking Alpha

For further details see: